80
Views
29
CrossRef citations to date
0
Altmetric
Original Article

Disseminated Intravascular Coagulation in Adult Acute Lymphoblastic Leukemia: Frequent Complications with Fibrinogen Levels Less than 100 mg/dl

, , , , , , , , & show all
Pages 85-92 | Received 29 May 1995, Published online: 01 Jul 2009

References

  • Sick, R. L. Baker, W. F. (1992) Disseminated intravascular coagu-lation syndromes. Hematologic Pathology, 6, 1–24.
  • Bovill, E. G. (1994) Laboratory diagnosis of disseminated in-travascular coagulation. Seminars Hernatol., 31,35–39.
  • Drapkin, R. L., Gee, T. S., Dowling, M. D., Arlin, Z., McKenzie, S., Kempin, S., Clarkson, B. (1978) Prophylactic heparin therapy in acute promyelocytic leukemia. Cancer, 41,2482–2490.
  • Cordonnier, C., Vernant, J. P., Brun, B., Heilmann, M. G., Kuentz, M., Bierling, P., Farcet, J. R., Rodet, M., Duedari, N., Imbert, M., Dreyfus, B., Rochant, H. (1985) Acute promyelocytic leukemia in 58 previously untreated patients. Cancer, 55, 18–25.
  • Goldberg, M. A., Ginsburgh, D., Mayer, R. J., Stone, R. M., Maguire, M., Rosenthal, D. S., Antin, J. H. (1987) Is heparin administration necessary during remission induction chemotherapy for patients with acute promyelocytic leukemia? Blood, 69, 187–191.
  • San-is, A. H., Kempin, S., Berman, E., Michaeli, J., Little, C., Andreeff, M., Gee, T., Straus, D., Gansbacher, B., Filippa, D., Glaser, B., Clarkson, B. (1992) High frequency of disseminated in-travascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia. Blood, 79, 1305–1310.
  • Myers, T. J., Rickles, F. R., Barb, C., Cronbud, M. (1981) Fibrinopeptide-A in acute leukemia: Relationship of activation of blood coagulation to disease activity. Blood, 57, 518–530.
  • Abshire, T. C., Gold, S. H., Odom. L. F., Carson, S. D., Hathaway, W. E. (1990) The coagulopathy of childhood leukemia: Thrombin activation or primary fibrinolysis. Cancer, 66,716–721.
  • Mitchell, L., Hoogendom, H., Giles, A. R., Vegh, P., Andrew, M. (1994) Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: Risk of thrombotic complications in L'asparaginase-induced antithrombin III deficiency. Blood, 83, 386–391.
  • Solano, C., Lopez, J., Gomez, N., Fernandez-Ranada, J. M. (1992) Hypofibrinogenemia with a low frequency of clinical complications is often found during induction therapy. Blood, 80, 1366–1367.
  • Kantarjian, H. M., Walters, R. S., Keating, M. J., Smith, T. L., O'Brien, S., Estey, E. H., Huh, Y. 0., Spinolo, J., Dicke, K., Barlogie, B., McCredie, K. B., Freireich, E. J. (1990) Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J. Clin. Oncol., 8,994–1004.
  • Claus, A. (1957) Gerinnungsphysiologische Schnellmethode zur bestimmung des fibrinogens. Acta Haematol., 17, 237–246.
  • Kaplan, E. L., Meier, P. (1958) Non-parametric estimation from in-complete observations. Journal of the American Statistical Association, 53, 257–481.
  • Mantel, N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports, 50, 163–170.
  • Atwan, D. G., Practical Statistics for Medical Research. 1991, London: Chapman and Hall. 194–197.
  • Mason, D. Y., Ingram, G. I. C. (1971) Management of the heredi-tary coagulation disorders. Semin. Hematol., 8, 158–188.
  • Inamoto, Y., Terao, T. (1985) First report of a case of congenital afibrinogenemia with succesful delivery. Am. J. Obstet. Gynecol., 153, 803–804.
  • McDonagh, J., Carrell, N., Disorders of fibrinogen structure andFunction, in Hemostasis and thrombosis: Basic principles and clin-ical practice, R. W. Colman, et al., Editors. 1987, Lippincott: Philadelphia. p. 301.
  • Chorba, T. L., Orenstein, J. M., Ney, A. B., Schwartz, B. S., Alabaster, 0., Kessler, C. M., Cohen, P., Schulof, R. S. (1985) Phenotypic and ultrastructural characterization of a medullary thy-mocyte acute lymphoblastic leukemia with cell ularprocoagulant ac-tivity. Cancer, 55, 675–681.
  • Barrowcliffe, T. W., Marshall, D. E., Trickett, T. E., Hubbard, A. R., Gray, E., Thorpe, R. (1989) Procoagulant activity of T lym-phoblastoid cells in extrinsic and intrinsic coagulation systems. Thromb. Haemost., 62, 880–884.
  • Alessio, M. G., Falanga, A., Consonni, R., Bassan, R., B. B. M., Donati, M. B., Barbui, T. (1990) Cancer procoagulant in acute lym-phoblastic leukemia. Eur. J. Heamatol., 45,78–81.
  • Barbui, T., Finazzi, G., Falanga, A., Battista, R., Rassan, R. (1993) Bleeding and Thrombosis in acute lymphoblastic leukemia. Leukemia Lymphoma, 11, Suppl 2,43–47.
  • Andoh, K., Kubota, T., Takada, M., Tanaka, H., Kobayashi, N., Maekawa, T. (1987) Tissue factor activity in in leukemia cells. Special reference to disseminated intravascular coagulation. Cancer, 59, 748–754.
  • Kubota, T., Andoh, K., Sadalcata, H., Tanaka, H., Kobayashi, N. (1991) Tissue factor released from leukemic cells. Thromb. Haemost., 65, 59–63.
  • Rapaport, S. I. (1991) The extrinsic pathway inhibitor: A regulator of tissue factor-dependent blood coagulation. Thromb. Heamost., 66,6–15.
  • De Stefano, V., Guggliotta, L., Mazzucconi, M. G., Loene, G., Mandelli, F. (1993) Hypercoagulability during induction therapy of acute lymphoblastic leukemia is of scarce clinical relevance. Blood, 81,2468–2469.
  • Hoeltzer, D., Thiel, E., Leffler, H., Bodenstein, H., Plaumann, L, Blichner, T., Urbanitz, D., Koch, P., Heimpel, H., Engelhardt, R., Muller, U., Wendt, F.-C., Sodomann, H., Rithl, H., Herrmann, F., ICaboth, W., Dietzfelbinger, H., Pratte, H., Lunsken, C., Hellriegbl, K.-P., Spors, S., Nowrousian, R. M., Fischer, J., Fülle, H., Mitrou, P. S., Pfreundschuh, M., Georg, C., Emmerlich, B., Queisser, W., Meyer, P., Labedzki, L., Essers, U., König, H., Mainzer, R., Herrmann, R., Messeger, D., Zwingers, T. (1984) Intensified therapy in acute lym-phoblastic and acute undifferentiated leukemia. Blood, 64,38–47.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.